Young women in southern Africa are most at risk of becoming infected with HIV. If they take a pre-exposure prophylaxis like Truvada it could change their lives.
Articles on Pre-exposure prophylaxis
Displaying 21 - 21 of 21 article
Top contributors
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Professor of Global Health and Director, O'Neill Institute, Georgetown University
-
Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand
-
Senior Scientist at CAPRISA, University of KwaZulu-Natal
-
Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Director of the Africa Centre for Population Health and Professor of Virology, University of KwaZulu-Natal
-
Researcher and Programme Manager: Clinical Research Consortium for Wits Reproductive Health and HIV Institute (RHI), University of the Witwatersrand
-
PhD candidate, Ghent University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Clinician-Scientist, St. Michael’s Hospital; Associate Professor, Faculty of Medicine, University of Toronto
-
Research Director at The Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal
-
Post-doctoral research fellow, University of KwaZulu-Natal
-
Physician-scientist, Harvard University
-
Doctoral Researcher, School of Public Health and Public Health Technical Advisor, Anova Health Institute, University of the Witwatersrand